argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
894.77
-36.61 (-3.93%)
At close: Nov 5, 2026, 4:00 PM EST
890.56
-4.21 (-0.47%)
Pre-market: Nov 6, 2026, 4:12 AM EST
argenx SE Market Cap
argenx SE has a market cap or net worth of $57.24 billion as of November 5, 2026. Its market cap has increased by 13.50% in one year.
Market Cap
57.24B
Enterprise Value
52.16B
1-Year Change
13.50%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $57.24B, an increase of 9,162.02%. That is a compound annual growth rate of 61.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 58.25B | 13.48% |
| Dec 31, 2025 | 51.33B | 39.57% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 140.20B |
| Regeneron Pharmaceuticals | 96.46B |
| Moderna | 88.16B |
| BeOne Medicines AG | 41.08B |
| Revolution Medicines | 40.33B |
| Royalty Pharma | 38.25B |
| Genmab | 33.12B |
| Roivant Sciences | 25.92B |